Literature DB >> 31127829

The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study).

Alvilde Maria Ossum1,2, Øyvind Palm3, Milada Cvancarova4, Tomm Bernklev2,5, Jørgen Jahnsen2,6, Bjørn Moum1,2, Marte Lie Høivik1.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) often suffer from musculoskeletal manifestations. Health-related quality of life (HRQoL) and fatigue are known to be associated with IBD activity and musculoskeletal complaints. The aim of this study was to determine the association between spondyloarthritis, arthralgia, or back pain and the patient-reported outcomes of HRQoL and fatigue in IBD patients 20 years after their diagnosis.
METHODS: The IBSEN cohort was followed prospectively for 20 years. At the 20-year follow-up, the patients answered detailed questionnaires regarding rheumatological manifestations, intestinal symptoms, HRQoL, and fatigue. Multiple regression analyses were used to evaluate associations between spondyloarthritis or joint symptoms and HRQoL or fatigue. Sex, IBD diagnosis, and age were included in all the multiple regression models, in addition to other clinically relevant confounders.
RESULTS: In total, 441 patients (94%) completed the questionnaires at the 20-year follow-up. The criteria for spondyloarthritis (axial or peripheral) were fulfilled in 158 patients (36%), current back pain during the previous 3 months was reported by 79 patients (18%), and current arthralgia was reported by 178 patients (40%). Current back pain and arthralgia were independently associated with lower HRQoL, higher levels of fatigue, and chronic fatigue. A diagnosis of spondyloarthritis was not associated with reduced HRQoL or fatigue when adjusted for possible confounders.
CONCLUSIONS: Current joint symptoms in IBD patients 20 years after diagnosis were associated with poorer HRQoL, higher levels of fatigue, and chronic fatigue, whereas spondyloarthritis did not impact HRQoL or fatigue negatively in this cohort.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IBD; arthritis; fatigue; quality of life; spondyloarthritis

Year:  2020        PMID: 31127829     DOI: 10.1093/ibd/izz105

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Screening for spondyloarthritis in patients with inflammatory bowel diseases.

Authors:  Sébastien Ottaviani; Xavier Tréton; Yoram Bouhnik; Philippe Dieudé; Marine Forien; Romain Coralli; Astrid Dauchez; Carmen Stefanescu; Anne-Laure Pelletier; Hakim Becheur; Esther Ebstein
Journal:  Rheumatol Int       Date:  2022-09-26       Impact factor: 3.580

2.  Pain Severity and Vitamin D Deficiency in IBD Patients.

Authors:  Svein Oskar Frigstad; Marte Lie Høivik; Jørgen Jahnsen; Milada Cvancarova; Tore Grimstad; Ingrid Prytz Berset; Gert Huppertz-Hauss; Øistein Hovde; Tomm Bernklev; Bjørn Moum; Lars-Petter Jelsness-Jørgensen
Journal:  Nutrients       Date:  2019-12-20       Impact factor: 5.717

Review 3.  Inflammatory Bowel Disease-related Spondyloarthritis: The Last Unexplored Territory of Rheumatology.

Authors:  Nikoleta Zioga; Dionysios Kogias; Vasiliki Lampropoulou; Nikolaos Kafalis; Charalampos Papagoras
Journal:  Mediterr J Rheumatol       Date:  2022-04-15

4.  Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn's disease.

Authors:  You-Jung Ha; Hyo Jin Kim; Eugene Lee; Ji Hye Park; Young Soo Park; Yun Jong Lee; Yusuhn Kang; Hyuk Yoon
Journal:  Korean J Intern Med       Date:  2021-03-22       Impact factor: 2.884

5.  The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency.

Authors:  Anna Zielińska; Aleksandra Sobolewska-Włodarczyk; Maria Wiśniewska-Jarosińska; Anita Gąsiorowska; Jakub Fichna; Maciej Sałaga
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-22

Review 6.  Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.

Authors:  Fenna M Jansen; Stephan R Vavricka; Alfons A den Broeder; Elke Mgj de Jong; Frank Hoentjen; Willemijn A van Dop
Journal:  United European Gastroenterol J       Date:  2020-09-14       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.